Fyarro Side Effects
Generic name: sirolimus protein-bound
Medically reviewed by Drugs.com. Last updated on Jun 4, 2024.
Note: This document provides detailed information about Fyarro Side Effects associated with sirolimus protein-bound. Some dosage forms listed on this page may not apply specifically to the brand name Fyarro.
Applies to sirolimus protein-bound: intravenous powder for suspension.
Serious side effects of Fyarro
Along with its needed effects, sirolimus protein-bound (the active ingredient contained in Fyarro) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking sirolimus protein-bound:
More common side effects
- bleeding gums
- blood in the urine or stools
- blurred vision
- chest pain
- chills
- confusion
- cough
- coughing up blood
- cracked lips
- decreased urine
- diarrhea
- difficulty in swallowing
- dizziness
- dry mouth
- fever
- flushed, dry skin
- fruit-like breath odor
- general feeling of discomfort or illness
- headache
- increased hunger
- increased menstrual flow or vaginal bleeding
- increased thirst
- increased urination
- irritation or soreness of the mouth
- lightheadedness
- loss of appetite
- mood changes
- muscle pain or cramps
- nausea or vomiting
- nervousness
- nosebleeds
- numbness or tingling in hands, feet, or lips
- painful or difficult urination
- pale skin
- paralysis
- pinpoint red spots on the skin
- pounding in the ears
- prolonged bleeding from cuts
- red or dark brown urine
- red or black, tarry stools
- slow, fast, or irregular heartbeat
- sore throat
- sores, ulcers, or white spots on the lips, tongue, or inside the mouth
- stomach pain
- sunken eyes
- sweating
- swelling of the hands, ankles, feet, or lower legs
- thickening of bronchial secretions
- trouble breathing
- unexplained weight loss
- unusual bleeding or bruising
- unusual tiredness or weakness
- wrinkled skin
Other side effects of Fyarro
Some side effects of sirolimus protein-bound may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- bleeding after defecation
- burning, numbness, tingling, or painful sensations
- constipation
- discoloration of the fingernails or toenails
- dry skin
- loss or thinning of the hair
- muscle or bone pain
- trouble sleeping
- uncomfortable swelling around the anus
- unsteadiness or awkwardness
- weakness in arms, hands, legs, or feet
For healthcare professionals
Applies to sirolimus protein-bound: intravenous powder for injection.
General adverse events
The most common adverse reactions were stomatitis (79%), fatigue and rash (68% each), infection (59%), nausea and edema (50% each), and diarrhea, musculoskeletal pain, and decreased weight (47% each).[Ref]
Cardiovascular
- Very common (10% or more): Hypertension (29%)[Ref]
Dermatologic
Dry skin (12%), nail disorder (12%)[Ref]
Gastrointestinal
- Very common (10% or more): Stomatitis (79%), nausea (50%), diarrhea (47%), vomiting (32%), abdominal pain (29%), constipation (24%), dry mouth (15%), hemorrhoids (12%)[Ref]
Hematologic
- Very common (10% or more): Hemorrhage (24%)[Ref]
Metabolic
- Very common (10% or more): Decreased appetite (444%), dehydration (15%)[Ref]
Musculoskeletal
- Very common (10% or more): Musculoskeletal pain - including arthralgias, back pain, myalgias (47%)[Ref]
Ocular
- Very common (10% or more): Blurred vision (12%)[Ref]
Other
- Very common (10% or more): Infections - upper respiratory tract infection, urinary tract infection, sinusitis, skin infection, folliculitis, nasopharyngitis, pharyngitis, pharyngitis streptococcal, pneumonia, vaginal infection (59%)[Ref]
Psychiatric
Respiratory
References
1. (2022) "Product Information. Fyarro (sirolimus protein-bound)." Aadi Bioscience, Inc.
More about Fyarro (sirolimus protein-bound)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: mTOR inhibitors
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Fyarro side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.